Related Experiment Video
Updated: Oct 20, 2025

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
Temporal bone squamous cell carcinoma: A change in treatment
C Y V Ngu1, M S Mohd Saad2, I P Tang2
1Sarawak General Hospital, Department of Otorhinolaryngology, Malaysia. vincengu1020@gmail.com.
Abstract:
Temporal bone squamous cell carcinoma (TBSCC) is a rare head and neck malignancy with the incidence 0.8 -1.0 cases in 1 million population. We are reporting a case series on the TBSCC cases that were operated on at Sarawak General Hospital, Malaysia. Ten patients were identified and collected with the presentation and type of surgery performed. It has been challenging for us to manage with recorded 2 years surviving in 6 out of 10 patients operated within this period. An adequate management with proper surgical resection of tumour and radiotherapy can extend the life expectancy for TBSCC patients.

